Screener
Merck & Co. MRK Acquired in-process research and development
Acquired in-process research and development at other companies
Other financials
Where this comes from
Reported directly by Merck & Co. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff.
The source filing: Merck & Co.’s 10-K, filed February 24, 2026.
- Filed
- Feb 24, 2026, 4:15 PM EST
- Fiscal year
- FY2026
- Accession
- 0000310158-26-000063
| Line item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation | 3,045 | 2,104 | 1,828 |
| Intangible asset impairment charges | 55 | 39 | 792 |
| Income from investments in equity securities, net | (368) | (14) | (340) |
| Charges for certain research and development asset acquisitions | — | 3,456 | 11,409 |
| Deferred income taxes | (1,671) | (1,249) | (1,899) |
| Share-based compensation | 820 | 761 | 645 |
| Other | 511 | 510 | 355 |
| Net changes in assets and liabilities: |
Item 8.Financial Statements and Supplementary Data.
FAQ
- What is Merck & Co.'s acquired in-process research and development?
- Merck & Co. (MRK) reported acquired in-process research and development of $0 in Q4 2025.
- How has Merck & Co.'s acquired in-process research and development changed year-over-year?
- Merck & Co.'s acquired in-process research and development decreased by 100.0% year-over-year, from $700M to $0.
- What is the long-term trend for Merck & Co.'s acquired in-process research and development?
- Over 3 years (2021 to 2025), Merck & Co.'s acquired in-process research and development has grown at a -100.0% compound annual growth rate (CAGR), from $1.56B to $0.
- What does acquired in-process research and development mean?
- Acquired in-process research and development represents the cash paid to acquire research projects that have not yet reached technological feasibility. In the pharmaceutical industry, this is a critical indicator of how a company is replenishing its product pipeline through external acquisitions. It represents a significant capital outlay aimed at future revenue growth.
Ask your AI about Merck & Co.'s acquired in-process research and development.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude